Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rectal misoprostol for reducing blood loss before hysterectomy and myomectomy
IRCT20181020041394N1Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of misoprostol in Fibromyoma (LM) (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoint: Bleeding. Started Jun 2018; status: completed.
02
Drugs
misoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT20181020041394N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181020041394N1.